Tirzepatide 15mg is a dual-agonist peptide that activates both GLP-1 and GIP receptors. It is widely studied for its significant effects on appetite suppression, improved insulin sensitivity, enhanced glycemic control, and substantial weight reduction. By targeting two incretin pathways simultaneously, Tirzepatide offers greater efficacy in metabolic regulation compared to single GLP-1 receptor agonists. Available in 5mg, 10mg, 15mg, and 20mg.